SCHEMBL16695191

SCHEMBL16695191

c1cc2c(cc1CCCN1CCC1)OCCO2

nearest known ligand 0.73

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.50
DPP7 Q9UHL4 1/20 0.49
SLC6A4 P31645 2/20 0.48
DRD2 P14416 1/20 0.48
SLC6A3 Q01959 1/20 0.48
ALDH1A1 P00352 2/20 0.47
MAPT P10636 1/20 0.47
HSD17B10 Q99714 1/20 0.47
LTA4H P09960 1/20 0.46
NPC1 O15118 1/20 0.46
TP53 P04637 1/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
TRPV1 Q8NER1 1/20 0.45
HPGD P15428 1/20 0.45
SIGMAR1 Q99720 4/20 0.44
POLB P06746 1/20 0.44
HTR1A P08908 2/20 0.43
HRH1 P35367 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2600465 0.97 DPP7 (0.52) CYP2D6DPP7SLC6A4DRD2SLC6A3
SCHEMBL16695160 0.95 ALDH1A1 (0.52) CYP2D6DPP7SLC6A4DRD2SLC6A3
SCHEMBL7996805 0.92 HRH1 (0.53) CYP2D6DPP7SLC6A4DRD2SLC6A3
SCHEMBL19043227 0.89 SIGMAR1 (0.58) CYP2D6ALDH1A1MAPTNPC1TP53
SCHEMBL19043651 0.85 ALDH1A1 (0.56) CYP2D6ALDH1A1MAPTNPC1TP53
SCHEMBL23731939 0.81 SIGMAR1 (0.44) CYP2D6SLC6A4ALDH1A1NPC1RAB9A
SCHEMBL20382666 0.81 DRD2 (0.48) SLC6A4DRD2SLC6A3ALDH1A1LTA4H
SCHEMBL22638788 0.81 ALDH1A1 (0.54) CYP2D6SLC6A4DRD2ALDH1A1MAPT
SCHEMBL13108661 0.80 SLC6A4 (0.46) CYP2D6SLC6A4DRD2ALDH1A1MAPT
SCHEMBL13108676 0.80 SLC6A4 (0.46) CYP2D6SLC6A4DRD2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3912977-A1 GLUCOSYLCERAMIDE SYNTHASE INHIBITORS FOR THE TREATMENT OF DISEASES BioMarin Pharmaceutical Inc. (US) 2021-11-24 EP disclosed
EP-3046920-B1 GLUCOSYLCERAMIDE SYNTHASE INHIBITORS FOR THE TREATMENT OF DISEASES BIOMARIN PHARM INC (US) 2021-08-04 EP disclosed
EP-3063141-B1 N-(1-HYDROXY-3-(PYRROLIDINYL)PROPAN-2-YL)PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS BIOMARIN PHARM INC (US) 2018-02-28 EP disclosed
WO-2015065937-A1 N-(1-HYDROXY-3-(PYRROLIDINYL)PROPAN-2-YL)PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS BIOMARIN PHARMACEUTICAL INC. (US) 2015-05-07 WO disclosed